lignin has been researched along with resiquimod in 1 studies
| Studies (lignin) | Trials (lignin) | Recent Studies (post-2010) (lignin) | Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) |
|---|---|---|---|---|---|
| 13,390 | 26 | 9,534 | 465 | 14 | 318 |
| Protein | Taxonomy | lignin (IC50) | resiquimod (IC50) |
|---|---|---|---|
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 2.056 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casettari, L; Figueiredo, P; Fontana, F; Hirvonen, J; Kostiainen, MA; Lepland, A; Santos, HA; Scodeller, P; Shahbazi, MA; Teesalu, T; Tiboni, M; Torrieri, G | 1 |
1 other study(ies) available for lignin and resiquimod
| Article | Year |
|---|---|
Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
Topics: Breast Neoplasms; Female; Humans; Imidazoles; Lignin; Nanoparticles; Peptides; Phenotype; Tissue Distribution; Tumor Microenvironment; Tumor-Associated Macrophages | 2021 |